Alpha-Blockers for Prostatitis: Tamsulosin, Alfuzosin & Symptom Relief

What are alpha-blockers?

Alpha-blockers are medications that relax smooth muscle by blocking alpha-1 adrenergic receptors. In the prostate, these receptors are found on smooth muscle cells in the prostate stroma and bladder neck.

By relaxing this muscle, alpha-blockers reduce urethral resistance and improve urine flow. They are primarily used for BPH (enlarged prostate) but are also effective for certain prostatitis symptoms.

Why use alpha-blockers for prostatitis?

Alpha-blockers help prostatitis patients in several ways:

• Relax prostate smooth muscle: Reduces urethral resistance and improves urine flow
• Reduce bladder neck tone: Decreases voiding symptoms (hesitancy, weak stream)
• May reduce pain: Some studies suggest alpha-blockers reduce pelvic pain (mechanism unclear)
• Adjunctive therapy: Used alongside antibiotics for bacterial prostatitis
• First-line for CP/CPPS urinary symptoms: Most effective for patients with significant voiding symptoms

Which alpha-blockers are used?

The same alpha-blockers used for BPH are used for prostatitis:

Tamsulosin (Flomax):

• Dose: 0.4 mg once daily (can increase to 0.8 mg)
• Most commonly prescribed
• Highly uroselective – fewer cardiovascular side effects
• Retrograde ejaculation rate: 8-18%

Alfuzosin (Uroxatral):

• Dose: 10 mg once daily
• Less uroselective than tamsulosin
• Lower retrograde ejaculation rate (2-5%)
• May cause mild hypotension

Silodosin (Rapaflo):

• Dose: 8 mg once daily (4 mg for renal impairment)
• Most uroselective – very low blood pressure effect
• Highest retrograde ejaculation rate (20-30%)
• Less commonly used for prostatitis

Doxazosin and Terazosin:

• Older, non-selective alpha-blockers
• Significant blood pressure lowering effect
• Require dose titration to avoid first-dose syncope
• Rarely used as first-line for prostatitis

Effectiveness for CP/CPPS (Type III)

CP/CPPS accounts for 90% of prostatitis cases. Alpha-blockers are a first-line treatment, especially for patients with urinary symptoms.

Evidence:

• Meta-analyses (Cochrane): Alpha-blockers modestly improve urinary symptoms (frequency, urgency, weak stream) in CP/CPPS
• Pain improvement: Less consistent – some studies show benefit, others do not
• Combination therapy: Alpha-blockers + anti-inflammatories or antibiotics (controversial) may be more effective
• Number needed to treat (NNT): ~6-8 for moderate symptom improvement

Who benefits most:

• Patients with prominent voiding symptoms (weak stream, hesitancy)
• Patients with high baseline IPSS scores (>15)
• Treatment-naive patients

Effectiveness for acute and chronic bacterial prostatitis

In bacterial prostatitis, alpha-blockers are adjunctive therapy – they do NOT replace antibiotics.

Acute bacterial prostatitis (Type I):

• Used to improve urinary flow and reduce voiding symptoms during acute infection
• May help prevent urinary retention
• Start after fever resolves (not during initial emergency treatment)

Chronic bacterial prostatitis (Type II):

• Used alongside long-term antibiotics (4-12 weeks)
• Improves voiding symptoms while antibiotics treat infection
• May be continued after antibiotics if symptoms persist

Evidence:

• Small studies show alpha-blockers improve symptom scores and flow rates in chronic bacterial prostatitis
• No evidence that alpha-blockers improve bacterial eradication (antibiotics are key)

Dosing and duration

Standard dosing:

• Tamsulosin: 0.4 mg once daily (with or without food)
• Alfuzosin: 10 mg once daily (immediately after the same meal each day)
• Silodosin: 8 mg once daily (with food)

Duration:

• Acute bacterial prostatitis: 4-6 weeks (alongside antibiotics)
• Chronic bacterial prostatitis: 4-12 weeks (alongside antibiotics)
• CP/CPPS: 4-12 weeks, then reassess. Some patients benefit from longer-term use

Monitoring:

• Reassess symptoms at 4-6 weeks
• If no improvement, consider discontinuing or switching to another alpha-blocker
• Monitor blood pressure (especially in elderly or those on antihypertensives)

Side effects – retrograde ejaculation, dizziness, nasal congestion

Common side effects (1-10%):

• Retrograde ejaculation: Semen goes into bladder instead of out (tamsulosin: 8-18%; alfuzosin: 2-5%; silodosin: 20-30%). Harmless but causes infertility.
• Dizziness/orthostatic hypotension: More common with alfuzosin, doxazosin, terazosin; less with tamsulosin/silodosin
• Nasal congestion (rhinitis): 5-10% (especially tamsulosin)
• Fatigue and weakness: 2-5%

Less common side effects:

• Headache
• Diarrhoea
• Abnormal ejaculation (reduced volume, not retrograde)

Important considerations:

• Alpha-blockers do NOT cause erectile dysfunction (unlike 5-ARIs)
• Retrograde ejaculation is the most common reason for discontinuation
• Switching to alfuzosin (lower rate) may help if retrograde ejaculation is bothersome

When NOT to use alpha-blockers

• Hypotension (low blood pressure): Systolic <90 mmHg or symptomatic orthostatic hypotension – can cause fainting
• Concurrent use of alpha-blockers for hypertension: Risk of additive hypotension
• Planned cataract surgery: Alpha-blockers (especially tamsulosin) can cause "floppy iris syndrome" during cataract surgery. Inform your ophthalmologist.
• Severe renal or hepatic impairment: Dose adjustment or avoidance needed for some agents (silodosin, alfuzosin)
• Concurrent PDE-5 inhibitors (Viagra, Cialis, Levitra): Can cause additive hypotension. Separate doses by 4-6 hours.

Interactive FAQ – Alpha-blockers for prostatitis

---

Disclaimer: This information is for educational purposes. Alpha-blockers are prescription medications. Consult a urologist at Vivekananda Hospital for proper diagnosis and treatment.